Britannia Life Sciences Inc.

CNSX:BLAB Stock Report

Market Cap: CA$11.4m

Britannia Life Sciences Past Earnings Performance

Past criteria checks 0/6

Britannia Life Sciences's earnings have been declining at an average annual rate of -0.07%, while the Professional Services industry saw earnings growing at 11.1% annually. Revenues have been growing at an average rate of 6% per year.

Key information

-0.07%

Earnings growth rate

30.0%

EPS growth rate

Professional Services Industry Growth11.6%
Revenue growth rate6.0%
Return on equity-112.5%
Net Margin-100.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Britannia Life Sciences (CSE:BLAB) Shareholders Will Want The ROCE Trajectory To Continue

Mar 01
Britannia Life Sciences (CSE:BLAB) Shareholders Will Want The ROCE Trajectory To Continue

Britannia Life Sciences (CSE:BLAB) Might Have The Makings Of A Multi-Bagger

Nov 14
Britannia Life Sciences (CSE:BLAB) Might Have The Makings Of A Multi-Bagger

Returns At Britannia Life Sciences (CSE:BLAB) Appear To Be Weighed Down

Apr 19
Returns At Britannia Life Sciences (CSE:BLAB) Appear To Be Weighed Down

A Look At The Fair Value Of Britannia Life Sciences Inc. (CSE:BLAB)

Mar 13
A Look At The Fair Value Of Britannia Life Sciences Inc. (CSE:BLAB)

Revenue & Expenses Breakdown

How Britannia Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:BLAB Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 247-730
30 Jun 247-540
31 Mar 248-540
31 Dec 237240
30 Sep 237140
30 Jun 237230
31 Mar 236540
31 Dec 227-140
30 Sep 227-1140
30 Jun 227-1340
31 Mar 227-1540
31 Dec 217-1030
30 Sep 215020
30 Jun 213010
31 Mar 211010

Quality Earnings: BLAB is currently unprofitable.

Growing Profit Margin: BLAB is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BLAB is unprofitable, and losses have increased over the past 5 years at a rate of 0.07% per year.

Accelerating Growth: Unable to compare BLAB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BLAB is unprofitable, making it difficult to compare its past year earnings growth to the Professional Services industry (9%).


Return on Equity

High ROE: BLAB has a negative Return on Equity (-112.51%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 01:34
End of Day Share Price 2025/01/29 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Britannia Life Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution